Nuclear factor-κB-independent anti-inflammatory action of salicylate in human endothelial cells: Induction of heme oxygenase-1 by the c-Jun N-terminal kinase/activator protein-1 pathway

Journal of Pharmacology and Experimental Therapeutics

Volumn 318, Issue 1, 2006, Pages 389-394

  Fürst, Robert ^a   Blumenthal, Signe B ^a   Kiemer, Alexandra K ^b   Zahler, Stefan ^a   Vollmar, Angelika M ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; ANTISENSE OLIGONUCLEOTIDE; HEME OXYGENASE 1; HEME OXYGENASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 4; PADGEM PROTEIN; PROTOPORPHYRIN TIN; SALICYLIC ACID; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; TRANSCRIPTION FACTOR AP 1;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DNA BINDING; DRUG ANTAGONISM; ENDOTHELIUM; ENDOTHELIUM CELL; ENZYME INDUCTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; ENZYME INDUCTION; HEME OXYGENASE-1; HUMANS; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 8; NF-KAPPA B; SALICYLATES; TRANSCRIPTION FACTOR AP-1;

EID: 33745243736     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.106.102251     Document Type: Article

References (41)

1. Aceves M, Duenas A, Gomez C, San Vicente E, Crespo MS, and Garcia-Rodriguez C (2004) A new pharmacological effect of salicylates: inhibition of NFAT-dependent transcription. J Immunol 173:5721-5729.
2. Adler V, Yin Z, Tew KD, and Ronai Z (1999) Role of redox potential and reactive oxygen species in stress signaling. Oncogene 18:6104-6111.
3. Alcaraz MJ, Fernandez P, and Guillen MI (2003) Anti-inflammatory actions of the heme oxygenase-1 pathway. Curr Pharm Des 9:2541-2551.
4. Amann R and Peskar BA (2002) Anti-inflammatory effects of aspirin and sodium salicylate. Eur J Pharmacol 447:1-9.
5. Battaglia V, Salvi M, and Toninello A (2005) Oxidative stress is responsible for mitochondrial permeability transition induction by salicylate in liver mitochondria. J Biol Chem 280:33864-33872.
6. Bennett BL, Sasaki DT, Murray BW, O'Leary EC, Sakata ST, Xu W, Leisten JC, Motiwala A, Pierce S, Satoh Y, et al. (2001) SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci USA 98:13681-13686.
7. Biedermann BC (2001) Vascular endothelium: checkpoint for inflammation and immunity. News Physiol Sci 16:84-88.
8. Bradding P, Feather IH, Howarth PH, Mueller R, Roberts JA, Britten K, Bews JP, Hunt TC, Okayama Y, and Heusser CH (1992) Interleukin 4 is localized to and released by human mast cells. J Exp Med 176:1381-1386.
9. Brune K (1977) Biodistribution of salicylates: a clue to the understanding of some effects and side effects. Agents Actions Suppl 2:163-177.
10. Cronstein BN, Montesinos MC, and Weissmann G (1999) Salicylates and sulfasalazine, but not glucocorticoids, inhibit leukocyte accumulation by an adenosine-dependent mechanism that is independent of inhibition of prostaglandin synthesis and p105 of NFkappaB. Proc Natl Acad Sci USA 96:6377-6381.
11. Dong Z, Huang C, Brown RE, and Ma WY (1997) Inhibition of activator protein 1 activity and neoplastic transformation by aspirin. J Biol Chem 272:9962-9970.
12. Drummond GS and Kappas A (1981) Prevention of neonatal hyperbilirubinemia by tin protoporphyrin IX, a potent competitive inhibitor of heme oxidation. Proc Natl Acad Sci USA 78:6466-6470.
13. Fürst R, Brueckl C, Kuebler WM, Zahler S, Krötz F, Görlach A, Vollmar AM, and Kiemer AK (2005) Atrial natriuretic peptide induces mitogen-activated protein kinase phosphatase-1 in human endothelial cells via Rac1 and NAD(P)H oxidase/Nox2-activation. Circ Res 96:43-53.
14. Grosser N, Abate A, Oberle S, Vreman HJ, Dennery PA, Becker JC, Pohle T, Seidman DS, and Schroder H (2003) Heme oxygenase-1 induction may explain the antioxidant profile of aspirin. Biochem Biophys Res Commun 308:956-960.
15. Huang C, Ma WY, Hanenberger D, Cleary MP, Bowden GT, and Dong Z (1997) Inhibition of ultraviolet B-induced activator protein-1 (AP-1) activity by aspirin in AP-1-luciferase transgenic mice. J Biol Chem 272:26325-26331.
16. Ishikawa K and Maruyama Y (2001) Heme oxygenase as an intrinsic defense system in vascular wall: implication against atherogenesis. J Atheroscler Thromb 8:63-70.
17. Jan JT, Chen BH, Ma SH, Liu CI, Tsai HP, Wu HC, Jiang SY, Yang KD, and Shaio MF (2000) Potential dengue virus-triggered apoptotic pathway in human neuroblastoma cells: arachidonic acid, superoxide anion and NF-kappaB are sequentially involved. J Virol 74:8680-8691.
18. Kiemer AK, Bildner N, Weber NC, and Vollmar AM (2003) Characterization of heme oxygenase 1 (heat shock protein 32) induction by atrial natriuretic peptide in human endothelial cells. Endocrinology 144:802-812.
19. Kiemer AK, Weber NC, Fürst R, Bildner N, Kulhanek-Heinze S, and Vollmar AM (2002a) Inhibition of p38 MAPK activation via induction of MKP-1: atrial natriuretic peptide reduces TNF-α-induced actin polymerization and endothelial permeability. Circ Res 90:874-881.
20. Kiemer AK, Weber NC, and Vollmar AM (2002b) Induction of IκB: atrial natriuretic peptide as a regulator of the NF-κB pathway. Biochem Biophys Res Commun 295:1068-1076.
21. Kopp E and Ghosh S (1994) Inhibition of NF-kappa B by sodium salicylate and aspirin. Science (Wash DC) 265:956-959.
22. Lavrovsky Y, Schwartzman ML, Levere RD, Kappas A, and Abraham NG (1994) Identification of binding sites for transcription factors NF-kappa B and AP-2 in the promoter region of the human heme oxygenase 1 gene. Proc Natl Acad Sci USA 91:5987-5991.
23. McCarty JM, Yee EK, Deisher TA, Harlan JM, and Kaushansky K (1995) Interleukin-4 induces endothelial vascular cell adhesion molecule-1 (VCAM-1) by an NF-kappa b-independent mechanism. FEBS Lett 372:194-198.
24. Murono S, Yoshizaki T, Sato H, Takeshita H, Furukawa M, and Pagano JS (2000) Aspirin inhibits tumor cell invasiveness induced by Epstein-Barr virus latent membrane protein 1 through suppression of matrix metalloproteinase-9 expression. Cancer Res 60:2555-2561.
25. Nascimento-Silva V, Arruda MA, Barja-Fidalgo C, Villela CG, and Fierro IM (2005) Novel lipid mediator aspirin-triggered lipoxin A4 induces heme oxygenase-1 in endothelial cells. Am J Physiol 289:C557-C563.
26. Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45.
27. Pillinger MH, Capodici C, Rosenthal P, Kheterpal N, Hanft S, Philips MR, and Weissmann G (1998) Modes of action of aspirin-like drugs: salicylates inhibit erk activation and integrin-dependent neutrophil adhesion. Proc Natl Acad Sci USA 95:14540-14545.
28. Sasaguri T, Arima N, Tanimoto A, Shimajiri S, Hamada T, and Sasaguri Y (1998) A role for interleukin 4 in production of matrix metalloproteinase 1 by human aortic smooth muscle cells. Atherosclerosis 138:247-253.
29. Schwenger P, Alpert D, Skolnik EY, and Vilcek J (1999) Cell-type-specific activation of c-Jun N-terminal kinase by salicylates. J Cell Physiol 179:109-114.
30. Schwenger P, Bellosta P, Vietor I, Basilico C, Skolnik EY, and Vilcek J (1997) Sodium salicylate induces apoptosis via p38 mitogen-activated protein kinase but inhibits tumor necrosis factor-induced c-Jun N-terminal kinase/stress-activated protein kinase activation. Proc Natl Acad Sci USA 94:2869-2873.
31. Tegeder I, Pfeilschifter J, and Geisslinger G (2001) Cyclooxygenase- independent actions of cyclooxygenase inhibitors. FASEB J 15:2057-2072.
32. Terry CM, Clikeman JA, Hoidal JR, and Callahan KS (1998) Effect of tumor necrosis factor-α and interleukin-1α on heme oxygenase-1 expression in human endothelial cells. Am J Physiol 274:H883-H891.
33. Tsuchihashi S, Fondevila C, and Kupiec-Weglinski JW (2004) Heme oxygenase system in ischemia and reperfusion injury. Ann Transplant 9:84-87.
34. Vane JR and Botting RM (2003) The mechanism of action of aspirin. Thromb Res 110:255-258.
35. Vartiainen N, Goldsteins G, Keksa-Goldsteine V, Chan PH, and Koistinaho J (2003) Aspirin inhibits p44/42 mitogen-activated protein kinase and is protective against hypoxia/reoxygenation neuronal damage. Stroke 34:752-757.
36. Wagener FA, da Silva JL, Farley T, de WT, Kappas A, and Abraham NG (1999) Differential effects of heme oxygenase isoforms on heme mediation of endothelial intracellular adhesion molecule 1 expression. J Pharmacol Exp Ther 291:416-423.
37. Wagener FA, Volk HD, Willis D, Abraham NG, Soares MP, Adema GJ, and Figdor CG (2003) Different faces of the heme-heme oxygenase system in inflammation. Pharmacol Rev 55:551-571.
38. Wong CK, Zhang JP, Lam CW, Ho CY, and Hjelm NM (2000) Sodium salicylate-induced apoptosis of human peripheral blood eosinophils is independent of the activation of c-Jun N-terminal kinase and p38 mitogen-activated protein kinase. Int Arch Allergy Immunol 121:44-52.
39. Xia L, Pan J, Yao L, and McEver RP (1998) A proteasome inhibitor, an antioxidant, or a salicylate, but not a glucocorticoid, blocks constitutive and cytokine-inducible expression of P-selectin in human endothelial cells. Blood 91:1625-1632.
40. Yachie A, Niida Y, Wada T, Igarashi N, Kaneda H, Toma T, Ohta K, Kasahara Y, and Koizumi S (1999) Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Investig 103:129-135.
41. Yao L, Pan J, Setiadi H, Patel KD, and McEver RP (1996) Interleukin 4 or oncostatin M induces a prolonged increase in P-selectin mRNA and protein in human endothelial cells. J Exp Med 184:81-92.